Clinical Trial of the TQB3602 Capsule Combined With AK105 Injection in

See also
Status	Clinical Trial	Phase
Completed	`NCT01213238` - Hepatic Arterial Infusion Oxaliplatin, Capecitabine With or Without Bevacizumab	Phase 1
Recruiting	`NCT02160366` - Profile Related Evidence to Determine Individualized Cancer Therapy (PREDICT) Program in Advanced Cancer Patients
Completed	`NCT00903708` - LY2275796 in Advanced Cancer	Phase 1
Completed	`NCT00379353` - The Effects of Thalidomide on Symptom Clusters	Phase 2
Terminated	`NCT00499382` - Quantitation of Left Ventricular Ejection Fraction as Part of F-18 FDG Whole Body PET/CT Scans For Tumor Staging	N/A
Completed	`NCT02459964` - Compare Fentanyl Nasal Spray With Intravenous Opioids to Treat Severe Pain	Phase 4
Completed	`NCT01430572` - Pazopanib and Everolimus in PI3KCA Mutation Positive/PTEN Loss Patients	Phase 1
Completed	`NCT02561234` - A Multiple Dose, Dose Escalation Trial of AEB1102 in Patients With Advanced Solid Tumors	Phase 1/Phase 2
Active, not recruiting	`NCT01375114` - The Effects of Ginseng on Cancer-Related Fatigue	Phase 2
Completed	`NCT01454804` - Pazopanib, Lapatinib or Trastuzumab in Subjects With Solid Tumors	Phase 1
Completed	`NCT01201694` - Phase I Study of Surface-Controlled Water Soluble Curcumin (THERACURMIN CR-011L)	Phase 1
Completed	`NCT02801045` - Art Therapy in Palliative Care: Study of Identification and Understanding of the Mechanisms of Change in the Patient	N/A
Completed	`NCT02873975` - A Study of LY2606368 (Prexasertib) in Patients With Solid Tumors With Replicative Stress or Homologous Repair Deficiency	Phase 2
Completed	`NCT01983969` - Aza-SAHA-GBM With AutoSCT for Refractory Lymphoma	Phase 1/Phase 2
Completed	`NCT02272595` - Rational Therapeutics Based on Matched Tumor and Normal Tissue
Active, not recruiting	`NCT01999491` - A Phase 1 Dose-Escalation and Pharmacokinetic Study of NC-4016 in Patients With Advanced Solid Tumors or Lymphoma	Phase 1
Recruiting	`NCT03375983` - Plasmodium Immunotherapy for Advanced Cancers	Phase 1/Phase 2
Completed	`NCT02571036` - A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies	Phase 1
Withdrawn	`NCT01608139` - Study of Curcumin, Vorinostat, and Sorafenib	Phase 1
Completed	`NCT01024166` - Patient-Reported Outcomes-Based Palliative and Hospice Care Practice: A Usability Study	N/A

NCT number	NCT05333276
Study type	Interventional
Source	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Contact
Status	Active, not recruiting
Phase	Phase 1
Start date	July 29, 2022
Completion date	May 2024

Clinical Trial of the TQB3602 Capsule Combined With AK105 Injection in Patients With Advanced Cancers

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms